Goldman Sachs’s Summit Healthcare Acquisition Corp. Class A Ordinary Share SMIH Stock Holding History

Goldman Sachs’s Portfolio SMIH Stock Details SMIH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q1	–	Sell	-301,857	Closed	-$3.03M	–	6404
2022 Q4	$3.03M	Hold	301,857	–	–	﹤0.01%	3609
2022 Q3	$2.96M	Sell	301,857 -2,000	-0.7%	-$19.6K	﹤0.01%	3616
2022 Q2	$2.96M	Sell	303,857 -3,900	-1%	-$38K	﹤0.01%	3689
2022 Q1	$2.99M	Hold	307,757	–	–	﹤0.01%	3863
2021 Q4	$2.98M	Buy	307,757 +297,078	+2,782%	+$2.88M	﹤0.01%	3894
2021 Q3	$104K	Buy	+10,679	New	+$103K	﹤0.01%	5900

Goldman Sachs's SMIH Position: Q1 2023 in Review

Goldman Sachs sold out of Summit Healthcare Acquisition Corp. Class A Ordinary Share (SMIH) in Q1 2023, closing a stake of 301,857 shares — an estimated $3.03M sold.

Goldman Sachs first reported a position in SMIH in Q3 2021 and held it in 6 quarters. The position peaked at $3.03M in Q4 2022. 0 funds tracked by Wall St. Rank hold SMIH as of Q1 2023.

Goldman Sachs reported no remaining Summit Healthcare Acquisition Corp. Class A Ordinary Share position as of Q1 2023 after selling out during the quarter.
Goldman Sachs sold 301,857 Summit Healthcare Acquisition Corp. Class A Ordinary Share shares in Q1 2023, an estimated $3.03M.
Goldman Sachs first reported a position in Summit Healthcare Acquisition Corp. Class A Ordinary Share in Q3 2021 and held it in 6 quarters.
Goldman Sachs's Summit Healthcare Acquisition Corp. Class A Ordinary Share position peaked at $3.03M in Q4 2022.
0 funds tracked by Wall St. Rank held Summit Healthcare Acquisition Corp. Class A Ordinary Share as of Q1 2023.

Based on Goldman Sachs's 13F filing for Q1 2023, filed 11 May 2023.